pending 2022 US20250333732A1
Treatment of SOS2 Related Diseases and Disorders
Inventors: Gregory McInnes
Plain Language Summary
Compositions comprising oligonucleotides (siRNA or ASO) that target SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2) for the treatment of related conditions.
RNA Therapeutics